While there is no cure for Alchemies Dementia at present, pharmacological and psychosocial treatments can delay the progression of the extensive brain damage and impart coping skills to provide teeter quality life to cope with the disorder. Researchers have also examined various risk and protective factors to prevent Alchemies Dementia (Barlow & Duran, 2012). Pharmacological treatments have shown significant effects to delay the onset of cognitive deficits in Alchemist’s dementia.
The primary treatment of AD is known as the cholinesterase inhibitors to prevent the breakdown of acetylene’s, a chemical messenger essential for learning and memory (Lisa & Bruce, 2010). O’Donnell and Representing are such common prescriptions that have assessed in clinical studies to show cognitive improvements in AD attentions of mild-to moderate severity (Lisa & Bruce, 2010). In treating moderate to severe patients, the MADAM inhibitor known as Meantime are given to unblock and normalize excess glutamate by shielding the damage of cells and preserve cognition (Lisa & Bruce, 2010).
Meantime has shown to induce substantial improvement in cognitive and functioning in a 28 weeks study in moderate-to severe AD patients (Lisa & Bruce, 2010). Other pharmaceuticals including vitamin E, and anomie oxides-B Selling are found to preserve motor-functions in over 300 moderately severe AD patients Lisa & Bruce, 2010). Agents such as estrogen and Ginkgo Bilbao have shown mostly inconsistent findings in trials to aid cognition in AD patients.
Patients with Alchemies Dementia are also prescribed anti-depressants to relieve mood abnormalities, Insomnia and agitation (Lisa & Bruce, 2010). Psychosocial interventions in Reality Orientation and Memory Training engage AD patients to improve cognitive and disorientation difficulties. Reality Orientation employs positive attitudes to heighten the patient’s sense of awareness of identity, date and time, happenings through environmental uses such as personal belongings, calendars, clocks, televisions and newspapers (Kaki-Godly & Gate, 2000).
Brook, Deign and Matter assessed a study Of 18 Alchemies Dementia patients who Were randomly assigned to OR groups or control group, it was found that OR groups maintained or improved significantly in cognitive and social functioning while the control group worsened (Sal-Godly & Gate, 2000). Memory training in memory wallets where pictures and sentences of familiar events, places and people has proven to be effective in reducing the demands on patient’s cognitive ability o remember (Sal-Goodie & Gate, 2000).
Bourgeois demonstrated in studies that AD patients have shown better conversational ability with the use of memory wallets, they made more factual statements of their personal information in conversations with people (Sal-Godly & Gate, 2000). Other psychosocial interventions in Reminiscence therapy, Counseling Support groups and psycho-educational programs focus on interpersonal and emotional assistance to cope with the challenging experiences faced with the disease.
Reminiscence therapy enables mild to moderate AD patients to collect memories of people, events and periods to connect them with attainments and positive actualization at this final state of life (Sal-Godly & Gate, 2000). This approach engages patients in life evaluation process using memorabilia such as old personal photographs, letters, biographies. A crossover examination by researchers found reminiscence therapy to be effective in enhancing cognition in a group of AD elderly in the nursing home, and it has also enhanced the emotional and mental health due to increase interaction with staff (Sal-Goodie & Gate, 2000).
Counseling support groups or family and caregivers can mitigate feelings of anger, frustration and guilt and provide support and alliance to facilitate management in treatment, medical, financial plans and long-term nursing placement for AD patients (Sal-Godly & Gate, 2000). A powerful randomized controlled study involving five sessions of individual and family counseling in 3 months of telephone counseling were conducted by social workers in three countries Australia, the United Kingdom and United states (Gallagher-Thompson et al. , 2012).
Results has shown that counseling support for the intervention group has proven successful in relieving emotional distress in depression over 3 months to 2 years as compared to the control group (Gallagher-Thompson et al. , 2012). Similarly, Psycho-educational programs in teaching skillets to cope with frustrations and negative behaviors of AD patients have found to improve the psychological wellbeing of caregivers. “Coping with Caregivers” is an example of one such successful intervention which has been adapted in several countries; United states, Spain, Australia and Hong Kong (Gallagher- Thompson et al. 2012). Prevention is the key to the Alchemies dementia and searchers have been looking into various risk and protective factors to reverse the signs of the disease. Risk element includes the advancement of age in elderly after 75 years old and the genetic risk of Pollination E (POE) ?4 allele(Misalliances, Xx & Exploit, 2013). Other health ailments in high cholesterol, diabetes mellitus, cardiovascular lesions, cardiovascular diseases, traumatic brain injuries, trepanned palladium and HIVE have also found to be associated with the development of Alchemies Dementia(Misalliances, Xx & Exploit, 2013).
Maintaining a healthy diet and epistyle can safeguard possible risk factors in Alchemies Dementia. Several longitudinal studies have proven that the optimal standard of Mediterranean diet in the regular intake of juju-3 polyunsaturated fatty acid in fish and high levels of antioxidants in Vitamin E and C from fruit and vegetables can protect cognition and reduce the incidences of dementia (Misalliances, Xx & Exploit, 2013).
However most importantly, keeping a mentally active and sound mind at work, social engagement, communal activities and physical exercise can provide significant insulation against the risk in Alchemies Dementia (Misalliances, Xx & Exploit, 2013). In conclusion, patients diagnosed with Alchemies Dementia may delay the onset of cognitive damage to the brain by pharmacological treatments and psychosocial interventions.